CLEVELAND, Ohio (News Talk 1480 WHBC and ONN) – The Cleveland Clinic is moving into the next phase of a vaccine for glioblastoma brain tumor patients.
It’s called Survax-M.
63 patients have been helped, and three of them are alive 5 and 6 years later with a type of tumor that is normally fatal.
Patient Katy Sanchez from Chelsea Michigan admits you’ll try anything with this diagnosis.
Neuro-Oncologist Doctor Mark Malkin says it’s nothing short of a medical breakthrough.
The next phase introduces a placebo for some patients.
For more info, call the Clinic at (216)-444-7923.